Table 1.
Subject Characteristics.
Table 2.
Descriptive Characteristics and Markers of Glycemic Control.
Fig 1.
Effect of SIT and MICT on VO2peak.
Measured at baseline (PRE), 6 weeks (MID), and 12 weeks (POST) in MICT, SIT and CTL. Values are means ± S.D. * p<0.05, vs. same group at PRE; # p<0.05, vs. same group at MID.
Fig 2.
Effect of SIT and MICT on insulin sensitivity.
The change in insulin sensitivity (CSI) over the 12-week intervention, measured from a 50-minute IVGTT in MICT, SIT and CTL. Closed circles denote individual responses. Values are means ± S.D. * p<0.05, PRE vs. POST.
Fig 3.
Effect of SIT and MICT on skeletal muscle mitochondrial content.
Measured in muscle biopsy samples obtained from the vastus lateralis before (PRE) and 96 h after (POST) the 12-week intervention in MICT, SIT and CTL. Maximal activity of citrate synthase (A), individual changes in maximal activity of citrate synthase (B) and protein content of various subunits from complexes in the electron transport chain (C). Representative western blots are shown. Values are means ± S.D. * p<0.05, vs. same group at PRE; † p<0.05, vs. CTL at POST.